Given that KRAS and BRAF mutations are generally mutually exclusive (21), genetic alterations of KRAS and BRAF were likely to occur in different colon tumors, implying that right-sided colon tumors are predisposed to harbor KRAS-BRAF pathway mutations. Here, KRAS is linked to colonic neoplasm.